IJMM International Journal of Molecular Medicine 1107-3756 1791-244X D.A. Spandidos 10.3892/ijmm.2022.5079 ijmm-49-03-05079 Corrigendum MicroRNA-24 attenuates diabetic vascular remodeling by suppressing the NLRP3/caspase-1/IL-1β signaling pathway FanZhixing YangJian YangChaojun ZhangJing CaiWanying HuangCongxin 03 2022 03 01 2022 49 3 24 Copyright: © Fan et al. 2022 This is an open access article distributed under the terms of the Creative Commons Attribution-NonCommercial-NoDerivs License, which permits use and distribution in any medium, provided the original work is properly cited, the use is non-commercial and no modifications or adaptations are made.

Int J Mol Med 45: 1534-1542, 2020; DOI: 10.3892/ijmm.2020.4533

Subsequently to the publication of the above article, the authors have realized that the immunohistochemical staining of CD31 in the 'Ad-NC group' portrayed in Fig. 7 on p. 1539 was published with an image that had been incorrectly captured from the 'Saline' group. This inadvertent error arose as a consequence of miscommunication between a pair of the authors on the paper when capturing the images.

The authors have re-examined their original data and identified the correct data for the Ad-NC group in Fig. 7. The corrected version of Fig. 7, showing the correct CD31 staining data for the Ad-NC group, is shown below. Note that this error did not affect the major conclusions reported in the paper. All the authors have agreed to this corrigendum, and apologize to the Editor of International Journal of Molecular Medicine and to the readership for any inconvenience caused.

Overexpression of miR-24 enhances reendothelialization. Immunohistochemical staining of the endothelial cell marker CD31 was performed and positive cells were stained brown and yellow. Magnification, ×400. Arrows indicate CD31-positive cells. Compared with the saline and Ad-NC groups, infection with Ad-miR-24 increased the expression of CD31 and the positively-stained area was larger and more continuous. A, adventitia; M, media; Ni, neointima; miR, microRNA; Ad, adenovirus; NC, GFP sequence.